Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA288342
Max Phase: Preclinical
Molecular Formula: C32H43F2N3O6
Molecular Weight: 603.71
Molecule Type: Small molecule
Associated Items:
ID: ALA288342
Max Phase: Preclinical
Molecular Formula: C32H43F2N3O6
Molecular Weight: 603.71
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2cc(F)cc(F)c2)[C@@H](O)C[C@@H](CC)C(=O)NCCCC(=O)O)c1
Standard InChI: InChI=1S/C32H43F2N3O6/c1-4-13-37(14-5-2)32(43)24-10-7-9-23(18-24)31(42)36-27(17-21-15-25(33)20-26(34)16-21)28(38)19-22(6-3)30(41)35-12-8-11-29(39)40/h7,9-10,15-16,18,20,22,27-28,38H,4-6,8,11-14,17,19H2,1-3H3,(H,35,41)(H,36,42)(H,39,40)/t22-,27+,28+/m1/s1
Standard InChI Key: UNMRHLWSLAAHOI-WWEDSPNTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 603.71 | Molecular Weight (Monoisotopic): 603.3120 | AlogP: 4.33 | #Rotatable Bonds: 18 |
Polar Surface Area: 136.04 | Molecular Species: ACID | HBA: 5 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.38 | CX Basic pKa: | CX LogP: 4.24 | CX LogD: 1.34 |
Aromatic Rings: 2 | Heavy Atoms: 43 | QED Weighted: 0.19 | Np Likeness Score: -0.67 |
1. Hom RK, Gailunas AF, Mamo S, Fang LY, Tung JS, Walker DE, Davis D, Thorsett ED, Jewett NE, Moon JB, John V.. (2004) Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human beta-secretase., 47 (1): [PMID:14695829] [10.1021/jm0304008] |
Source(1):